Wire Stories
Bridge Biotherapeutics to Present Tuesday at the BIO International Convention
SEONGNAM, South Korea & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Bridge Biotherapeutics Inc. (KQ288330), a South Korean clinical-stage biotechnology company focused on developing novel drugs for...